The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Acalabrutinib
Australian Public Assessment Report
Device/Product Name
Calquence
Active ingredients
Acalabrutinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-03536-1-6
Submission Type
New chemical entity
Decision
Approved for provisional registration